Arq. Bras. Cardiol. 2022; 118(4): 797-857

Joint Guideline on Venous Thromboembolism – 2022

Ana Cristina Lopes Albricker ORCID logo , Cláudia Maria Vilas Freire ORCID logo , Simone Nascimento dos Santos ORCID logo , Monica Luiza de Alcantara ORCID logo , Mohamed Hassan Saleh, Armando Luis Cantisano ORCID logo , José Aldo Ribeiro Teodoro, Carmen Lucia Lascasas Porto ORCID logo , Salomon Israel do Amaral, Orlando Carlos Gloria Veloso, Ana Cláudia Gomes Pereira Petisco ORCID logo , Fanilda Souto Barros ORCID logo , Márcio Vinícius Lins de Barros ORCID logo , Adriano José de Souza, Marcone Lima Sobreira ORCID logo , Robson Barbosa de Miranda ORCID logo , Domingos de Moraes, Carlos Gustavo Yuji Verrastro, Alexandre Dias Mançano ORCID logo , Ronaldo de Souza Leão Lima ORCID logo , Valdair Francisco Muglia ORCID logo , Cristina Sebastião Matushita ORCID logo , Rafael Willain Lopes ORCID logo , Artur Martins Novaes Coutinho ORCID logo , Diego Bromfman Pianta ORCID logo , Alair Augusto Sarmet Moreira Damas dos Santos ORCID logo , Bruno de Lima Naves ORCID logo , Marcelo Luiz Campos Vieira, Carlos Eduardo Rochitte ORCID logo

DOI: 10.36660/abc.20220213

Introduction

Venous thromboembolism (VTE) manifests as pulmonary embolism (PE) and/or deep vein thrombosis (DVT), being part of the same disease spectrum and presenting the same risk factors. It is the third most common cause of acute cardiovascular syndrome worldwide, being potentially life-threatening. ,

In Brazil, according to data from the Ministry of Health collected between 2010 and 2021, the number of hospitalizations for VTE exceeded 520,000, with a total of more than 67,000 deaths from 2010 to 2019.

[…]

Joint Guideline on Venous Thromboembolism – 2022

Comments

Skip to content